Download PDF
1 / Pages

Other users also viewed these articles

The steatosis-associated fibrosis estimator (SAFE) outperformed the FIB-4 score in screening the population for liver disease Mingkai Li; Ying Lin; Hongsheng Yu; Weichun Lin; Jianning Chen; Yidong Yang; Bin Wu;
10.1016/j.aohep.2024.101516
Impact of preoperative nonselective beta-blocker use on acute kidney injury after living donor liver transplantation: Propensity score analysis Hye-Won Jeong; Jae Hwan Kim; Sang-bin Han; Hye-Mee Kwon; In-Gu Jun; Jun-Gol Song; Gyu-Sam Hwang;
10.1016/j.aohep.2024.101474
From evidence to clinical practice: Bridging the gap of new liver cancer therapies in Latin America. Federico PiƱero; Ezequiel Mauro; Paola Casciato; Alejandro Forner;
Ann Hepatol. 2024;29: